rabies viruses, negative-strand rna viruses, infect neurons through axon terminals and spread trans-synaptically in a retrograde direction between neurons. rabies viruses whose glycoprotein (G) gene is deleted from the genome cannot spread across synapses. complementation of G in trans, however, enables trans-synaptic spreading of G-deleted rabies viruses to directly connected, presynaptic neurons. recombinant rabies viruses can encode genes of interest for labeling cells, controlling gene expression and monitoring or manipulating neural activity. cre-dependent or bridge protein-mediated transduction and single-cell electroporation via the enva-tVa or envB-tVB (envelope glycoprotein and its specific receptor for avian sarcoma leukosis virus subgroup a or B) system allow cell type-specific or single cell-specific targeting. these rabies virus-based approaches permit the linking of connectivity to cell morphology and circuit function for particular cell types or single cells. Here we describe methods for construction of rabies viral vectors, recovery of G-deleted rabies viruses from cDna, amplification of the viruses, pseudotyping them with enva or envB and concentration and titration of the viruses. the entire protocol takes 6-8 weeks.
IntroDuctIon
The mammalian brain is assembled from thousands of neuronal cell types, which are organized in distinct circuits to perform computations that give rise to perception, cognition and behavior. Knowledge of how neural circuits process and represent information is central to understanding how the brain functions and the causes of neurological disorders, and this subject has attracted the interest of neuroscientists over many decades. Although technological advances have been providing enormous opportunities to understand the principles organizing complex neural circuits at multiple levels using models including invertebrates, mice and primates [1] [2] [3] [4] [5] , a central problem is the identification of the structural and functional links between component neurons.
To elucidate how specific neural components contribute to the computations that generate perception, cognition and behavior, it will be key to resolve connectivity with high resolution, and then to correlate the function of circuit components with their connectivity. From these results, it will be possible to generate hypotheses that can be tested by manipulating the activity of selected components, monitoring the changes in the activity of other components within the networks and assessing the behavioral outcomes. The use of G-deleted rabies virus systems, as described here, will enable these strategies by facilitating the studies of the structure and function of complex neural circuits at the level of resolution of specific cell types and even single neurons .
Tracing circuits with rabies virus
Methods for elucidating connectivity across the whole brain at the level of resolution of specific cell types or single neurons can add considerably to our understanding of neural circuits. Such methods of investigating circuits in living animals can reveal direct correlations between circuit structure and function, and they can allow the perturbation of connectionally defined neural populations.
To facilitate such studies, we have developed genetically engineered rabies virus systems 6,7,10-13 . Rabies virus is a naturally occurring tracer that travels exclusively in the retrograde direction [30] [31] [32] and only between neurons connected by conventional synaptic contacts 7, 31, 32 . The envelope glycoprotein of the rabies virus allows retrograde infection through axon terminals, so that long-distance projection neurons can be selectively labeled on the basis of their connectivity to infected postsynaptic neurons . Rabies glycoprotein (G) is essential for virus packaging and transsynaptic spreading, but not for the transcription of viral genes or for the replication of the viral genome 6, 7, 33, 34 . The deletion of G from the viral genome can restrict trans-synaptic spread in the nervous system 6, 7, 34 . The G-deleted rabies viruses cannot spread after initial infection unless an alternative source of G is present. This results in the complete filling of axons and dendrites with fluorescent proteins (GFP, mCherry, DsRed or BFP), which allows detailed anatomical and morphological investigations 6, 8, 9, 15 . Notably, supplying the missing glycoprotein in trans within cells that are infected with G-deleted rabies virus allows the virus to spread to monosynaptic input cells that are directly connected to the initially infected neurons without further spread across additional synapses 7, 11, 13, 14, [16] [17] [18] [19] [20] [21] 23, 24, 26, 35 . To introduce and complement G in starter cells (postsynaptic neurons), various viral vectors, such as adeno-associated virus (AAV), lentivirus and herpes simplex virus (HSV), as well as genetically engineered mice have been proven to be effective for transcomplementation trans-synaptic tracing in vivo 11, 14, [16] [17] [18] [19] 21, 23, 24, 35 . Some of the published plasmids for these helper viruses are available from Addgene (http://www.addgene.org/).
The recombinant G-deleted rabies viruses can encode any genes of interest 13 . Therefore, cell labeling, gain-of-function and lossof-function analyses of a particular gene, as well as activation and silencing of particular neural circuits and monitoring of neural activity, are all possible in connectionally defined neuronal networks 13 . For instance, genetically encoded calcium indicators (GCaMP, RCaMP and TNXXL) [36] [37] [38] , voltage sensors (VSFP and Arch) 39, 40 or glutamate sensors (iGluSnFR) 41 enable the monitoring of neural activity in connectionally defined
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neurons and/or genetically targeted neurons. Ligand-gated (allatostatin receptor, DREADD and PSAM) [42] [43] [44] [45] or light-gated ion channels or pumps (channelrhodopsin, halorhodopsin and archaerhodopsin) [46] [47] [48] can reversibly control neural activity to address causal relationships. In addition, photoactivation of channelrhodopsin-expressing neurons can reveal the synaptic outputs of the infected neurons both in slice preparations and in vivo 49, 50 . Cre, FLP (flippase), tetracycline-controlled transactivator (tTA) and reverse tTA (rtTA) derived from the rabies viral genome can control gene expression when they are used with genetically engineered animals or in combination with helper viruses 13 . Conditional expression of genes facilitates experiments aimed at gain of function, loss of function and circuit tracing. Temporally controlled tracing across multiple synapses should also be possible by interfacing G-deleted rabies viruses with the increasing number of mouse lines and viral vectors that express rabies glycoprotein in a Cre-, FLP-, tTA-, or rtTA-dependent manner 13, 25, 29, 35 . These G-deleted rabies virus systems enable us to relate connectivity to detailed cell morphology 6, 7, [10] [11] [12] 15 as well as to circuit function 13, 22, 25, 27 .
Although there are numerous advantages of using G-deleted rabies virus-based methods for the study of neural circuits, it is also important to consider the limitations. Most notably, rabies virus infection will eventually induce cytotoxicity in infected neurons 6 . A working time window, during which functional studies of neurons infected by G-deleted rabies viruses are feasible, is typically between about 4 and 11 d after infection 13 . Reduction of cytotoxicity is one of the hurdles to be resolved for long-term experiments. Another limitation, in contrast to DNA viruses, is that the rabies virus cannot use promoterspecific expression of transgenes because rabies virus is an RNA virus and never produces DNA at any stage of its lifecycle.
To achieve cell type-specific targeting, we have developed the TVA-EnvA and TVB-EnvB systems 7, [10] [11] [12] [13] . EnvA and EnvB are envelope proteins from the avian sarcoma leucosis viruses subgroups A and B, and they specifically bind to the TVA and TVB receptors, respectively, which are not expressed in mammals 51 . Chimeric glycoproteins that consist of the ectodomain of EnvA or EnvB and the cytoplasmic domain of the rabies glycoprotein can pseudotype G-deleted rabies viruses 7, 10 . By taking advantage of this specificity and the lack of native receptors for EnvA or EnvB in mammalian cells, virus infection of EnvA-or EnvB-pseudotyped rabies can be limited to those genetically targeted neurons that express TVA or TVB 7, [11] [12] [13] 17, 19, 20, 23, 24, 26, 35 . In particular, transgenic or knock-in mice expressing Cre, FLP or rtTA under the control of a cell type-specific promoter can be used to obtain expression of TVA selectively in specific cell types 52 , allowing specific infection with EnvA-pseudotyped G-deleted rabies viruses 11, 17, 23, [53] [54] [55] . Newly generated connections of adult neural stem cell-derived neurons or embryonic stem cellderived neurons can also be detected by the introduction of TVA and G, followed by infection with EnvA-pseudotyped G-deleted rabies viruses 24, 26 . In addition, bridge proteins, which are fusion proteins of a ligand with TVB, are useful for cell typespecific transduction 10, 14 . Co-injection of EnvB-pseudotyped rabies viruses with the neuregulin-TVB bridge protein can preferentially target inhibitory cortical neurons that express the neuregulin receptor ErbB4. Moreover, electroporation and targeted patching of single cells of interest in vivo to introduce TVA, followed by infection of the TVA-expressing cells with EnvA-pseudotyped rabies viruses, allows the analysis of single neuronal networks with single-cell resolution 12, 20 . In summary, monosynaptically restricted labeling systems with G-deleted rabies virus make it possible to:
Identify neurons projecting to the injection site [7] [8] [9] 13, 15, 22, 27, 28 Identify neurons that are directly presynaptic to specific types of projection neurons 16, 18, 21, 25 Identify neurons that are directly presynaptic to specific genetically defined cell types 11, 14, 17, 19, 23, 24, 26 Identify neurons that are directly presynaptic to single, functionally characterized neurons 12, 20 Relate neuronal connectivity to detailed cell morphology 6, 7, [10] [11] [12] 15 Relate connectivity to circuit function 13, 22, 25, 27 Rabies virology To fully understand the advantages and disadvantages of rabies viruses, as well as the factors that need to be considered when designing rabies viral vectors, producing G-deleted rabies viruses at high titer, pseudotyping rabies viruses with other envelope proteins targeting rabies virus infection to particular cell types and troubleshooting during the development of experimental procedures ( Fig. 1) , it is important to understand rabies virology.
Rabies virus is a nonsegmented negative-strand RNA virus belonging to the Rhabdoviridae 56 . The virion structure is a bullet-shaped particle, ~250 nm in length and 70 nm in diameter. The rabies virus genome is composed of single-stranded, linear, negative-sense RNA and has a length of 11-12 kb. The five virus proteins N, P, M, G and L are encoded in the genome in the order 3′-N-P-M-G-L-5′ (Fig. 2a) . Transcription starts with a short uncapped leader RNA from the 3′ end of the genomic RNA. The viral genome RNA serves as a template for transcription by the RNA-dependent RNA polymerase complex, composed of the large protein (L) and the phosphoprotein (P), which results in the synthesis of mRNA for N, P, M, G and L. The replication of negative-strand genomes produces full-length positive-strand RNA, or antigenomes. The antigenomes serve as templates for the synthesis of progeny negative-strand genomes. The genomic RNA and the complementary antigenome RNA are tightly encapsidated by the nucleoprotein (N) to form the helical ribonucleoprotein (RNP). Only RNP is suitable as a template for replication and transcription, not free RNA. The viral capsid is surrounded by the host cell-derived membrane that interacts with two viral proteins, the matrix protein (M) and the glycoprotein (G). The G is an envelope protein and is essential for budding and for the trans-synaptic spread of infectious virion 7, 33 . The M interfaces between the RNP and G and is essential for virus packaging and the regulation of replication and transcription 57 .
It should be noted that the transcriptional machinery for rabies virus genome-derived RNA is completely different from transcription in host cells using DNA-dependent RNA polymerases such as PolII. The life cycle of rabies virus is confined to the cytoplasm, and rabies viruses do not have reverse transcriptases, which generate DNA from RNA. As a result of these characteristics, rabies viruses pose no risks of chromosomal insertion in the host cells, in contrast to retroviruses such as human immunodeficiency virus (HIV) and Moloney murine leukemia virus (MoMLV), which pose the danger of insertional mutagenesis in the host genome, leading to unpredictable gain or loss of function, such as tumor formation and loss of physiological properties 58, 59 .
In 1994, Schnell et al. 60 succeeded in cloning the cDNAs of each rabies virus gene and recovering rabies virus from DNA.
•
This landmark study was the first successful recovery of negative-strand RNA virus from the DNA 60 . Although reverse genetics systems have become more reliable and several improved methods have been reported, the efficiency of virus recovery is still lower than that of positive-strand RNA viruses or DNA viruses. Practical applications for neuroscience and biomedical research have been considerably limited. Recovery of G-deleted rabies viruses was particularly inefficient 33, 61 . We have also cloned viral cDNA by reverse genetics and developed new G-deleted rabies viral vectors and packaging cells in order to efficiently develop useful tools for neural circuit research 13 . All of the plasmids we generated for G-deleted rabies virus production are available from Addgene. Cells for virus production and G-deleted rabies virus starter stocks are also available from the Callaway laboratory at the Salk Institute for Biological Studies (http://www.salk.edu/).
Each junction between the coding sequences for rabies viral genes within the genome contains a sequence specifying the end of the upstream gene, an intergenic sequence and the start sequence for a downstream gene. These sequences function as a signal for polyadenylation and termination of the upstream RNA and also as a signal for the initiation, capping and methylation of the downstream RNA. Intergenic regions of rabies virus are variable in length and nucleotide composition; intergenic regions of N-P, P-M, M-G and G-L are 2, 5, 5 and 24 nt, respectively 62 . Expression of two foreign genes from our G-deleted rabies vectors (pSAD∆G-F3) is achieved by joining them with a stop sequence, a 2-nt intergenic sequence and a start sequence derived from between the N and P coding sequences that are presumably more efficient than other longer junctions 13, 63 . In some plasmids, this stop and start cassette is flanked with two multiple-cloning sites to facilitate insertion of one or two transgenes of interest 13 (Fig. 2b) . Because rabies virus is an enveloped virus, G-deleted rabies virus can be pseudotyped to produce particles incorporating non-native envelope proteins and alter its tropism 7, 14, 64 . The native envelope G of rabies viruses is able to facilitate infection of neurons through axon terminals 65, 66 . Although the G receptors responsible for retrograde infection have not been fully understood, the putative receptors include nicotinic acetylcholine receptors, the neural cell adhesion molecule (NCAM) and p75 neurotrophin receptors, but their expression levels are likely to vary depending on neuron types 67 . This feature of G allows retrograde infection and retrograde trans-synaptic spreading of rabies virus to presynaptic neurons [6] [7] [8] [9] [10] [11] [12] [13] [14] [16] [17] [18] [19] [20] [21] 23, 15 . In addition, G-deleted rabies viruses can be pseudotyped with the glycoprotein of vesicular stomatitis virus (VSV-G) and used as an anterograde tracer. VSV-G-pseudotyped G-deleted rabies viruses infect neurons around an injection site and make it possible to visualize axonal projections of neurons locally infected by the virus. In contrast, to selectively target desired neuronal subsets in mammals, G-deleted rabies viruses can be pseudotyped with envelope proteins from the avian sarcoma leucosis viruses EnvA and EnvB, which specifically bind to the avian-specific receptors TVA and TVB, respectively 7, 10, 51 . Targeted expression of TVA or TVB in particular cell types or single neurons permits specific infection by rabies viruses pseudotyped with EnvA or EnvB, respectively, and subsequent labeling of the monosynaptically restricted inputs to the population by G complementation 7, 10, 11, 13, 14, 17, 19, 20, 23 .
Experimental design
The following is an overview of the protocols that we have developed for the production of G-deleted rabies viruses. Although our protocols follow the same basic principles established in previous recovery systems 33, 61 , there are several specific changes that we have found to lead to greater success in viral recovery and to aid in the ability to more routinely produced high-titer G-deleted viruses. The production of rabies virus consists of six main stages: to design and construct a rabies viral genome plasmid encoding the genes of interest (stage I), to recover the novel rabies virus from the plasmid DNA (stage II), to amplify the rabies virus to high titers (stage III), to pseudotype the virus with EnvA or EnvB (stage IV), to concentrate the virus (stage V) and to titer the virus (stage VI; Figs. 1 and 3 ). In the event that an available starter stock for a particular rabies virus already exists, stages I and II are not necessary. Stage IV is only required if you are making pseudotyped virus.
With regard to biosafety, G-deleted rabies viruses are unable to spread beyond initially infected cells, and there are no reports of recombination of the viral genome of Rhabdoviridae with DNA or RNA. The production of recombinant G-deleted rabies virus should be performed in a laboratory operating at Biosafety Level 2, as approved by the researcher's institutional biosafety committee. This requires safety precautions including the use of biosafety cabinet hoods, the establishment of proper procedures for decontamination and disposal of liquid and solid wastes and the disinfection of contaminated surfaces and equipment. For virus injection in animals, animal protocols should be approved by an institutional committee.
Stage I: design and construction of rabies virus vector
We have created a plasmid that is broadly useful and convenient for cloning novel genes into the rabies viral genome (pSAD∆G-F3; Fig. 2b ; ref. 13) . Several strategies are available to ligate foreign DNA to plasmid vectors. We prefer not to carry extra sequences before and after the open reading frame (ORF) because viral vectors have a limited capacity in the genome size. Thus, we amplify the ORF with restriction enzymes sites at both ends by PCR with high-fidelity polymerase that possesses 3′-5′ exonuclease proofreading activity (Table 1) , thereby allowing us to clone the ORF without extra sequences. A list of restriction enzymes that produce compatible ends for efficient cloning of foreign DNA is in Table 2 . We also use the In-Fusion system, a new cloning technology from Clontech, which is versatile for directional cloning, because it does not require digestion of PCR products, filling with Klenow nor dephosphorylation with calf intestinal alkaline phosphatase (CIP) or bacterial alkaline phosphatase (BAP). For details on general molecular biology techniques such as PCR, DNA ligations, Escherichia coli transformations, E. coli culture, purification of plasmid DNA, restriction enzyme analysis and DNA sequencing, we recommend referring to Molecular Cloning: A Laboratory Manual 68 .
For the expression of multiple genes from the rabies viral genome, the use of a rabies virus transcription start and stop cassette is most reliable 13 . Alternatively, a 2A-mediated polycistronic expression system can express multiple transgenes via a translation skip mechanism 69 . However, this can result in the incomplete separation of two upstream and downstream proteins. A functional examination of the transgene products, especially upstream proteins, should be performed when you are using the 2A system because several amino acids derived from the 2A segment are attached to the carboxyl end of the upstream protein and 1 aa is attached to the amino end of the downstream protein. Targeting signals can also be hindered in the 2A system, depending on the subcellular localization of the proteins. Although internal ribosomal entry site-mediated multicistronic expression enables the production of two untagged proteins 70 , the translation efficiency of a downstream gene is much lower than that of an upstream gene 71, 72 . Another good option is expressing fusion proteins as a single ORF by introducing a fluorescent reporter tag (e.g., GFP or mCherry) or an epitope tag (e.g., c-Myc or hemagglutinin (HA)) that is as efficient as channelrhodopsin 2 (ChR2)-mCherry and mCherry-Myc 13 .
We have worked with transgenes of sizes between 0.7 kb and 3.7 kb, and we have found that there was no consistent relationship between size and viral titer 13 . The largest insert that we have made for our rabies viral vector is 3.7 kb, consisting of GFP (0.7 kb), ER T2 CreER T2 (tamoxifen-inducible Cre: 2.9 bp), a transcription stop sequence and a transcription start sequence. The total genome size is 13.6 kb (two transgenes (GFP and ER T2 CreER T2 ), with four native viral genes (N, P, M and L)); this is 1.7 kb larger than the native SAD-B19 genome of 11.9 kb (ref. 62) . The SAD∆G-GFP-ER T2 CreER T2 virus can grow to a high titer and infect neurons in a retrograde direction in vivo as other G-deleted rabies viruses do 13 .
Stage II: recovery of G-deleted rabies virus from cDNA
The rabies virus genomic sequence in the SAD∆G-F3 is flanked by hammerhead ribozyme (HamRz) 73 and hepatitis delta ribozyme (HdvRz) 74 for the processing of both the 5′ and 3′ ends of the viral genome 13 . To initiate an infectious cycle during recovery, full-length positive-sense RNA has to be transcribed from a rabies virus genomic plasmid by T7 polymerase and then immediately encapsidated in the transfected cells. Accordingly, the viral RNA polymerase complex (L and P proteins) and nucleocapsid (N proteins) are provided by simultaneously transfecting producer cells with the genomic plasmid (pSAD∆G) and the plasmids encoding these proteins (pcDNA-SADB19N, pcDNA-SADB19P and pcDNA-SADB19L) in order to allow the initiation of replication and subsequent transcription. The encapsidated virus genome and B7GG packaging cells (BHK cells expressing T7 RNA polymerase, rabies glycoprotein SADB19G and histone-tagged GFP are referred to as 'B7GG cells') express M and G, respectively, which are required to produce new virus particles. The key point of efficient recovery is the generation of positive-strand antigenome RNA from DNA 60 . Otherwise, the RNA derived from helper plasmids encoding N, P and L could hybridize to negative-strand genomic RNA and interfere with the initial assembly of RNPs.
We have established packaging cells, called B7GG cells, expressing T7 RNA polymerase, rabies virus G and histone 2B-tagged GFP, to efficiently recover G-deleted rabies viruses from plasmid DNA 13 . New virions produced by B7GG cells will be released into the medium, which will infect adjacent cells and result in the formation of fluorescence-positive clusters (Fig. 4) . A single particle of G-deleted rabies virus is sufficient for recovery and amplification because the virion infects an adjacent B7GG cell, which transcomplements G and amplifies the virus further. When there are large numbers of fluorescence-positive clusters, the virus recovery is successful. Although Mebatsion et al. 33 showed that noninfectious spikeless virions can bud out even in the absence of G (ref. 33) , we confirmed by monitoring fluorescence derived from the rabies virus that G-deleted rabies viruses expressing GFP or mCherry are unable to produce any functional, infectious virions in the absence of G. Many reports support this feature of the G-deleted rabies viruses .
Stage III: amplification of G-deleted rabies virus
The quality of the virus depends on the condition of the producer cells. It is important to keep the producer cells healthy for 5-6 d during the virus production. This can be achieved by maintaining them in a humidified atmosphere of 3% CO 2 at 35 °C. Although rabies viruses can grow at 37 °C, cells overgrow at 37 °C when they are cultured for longer periods, and they start to die before the viruses have sufficient time to amplify. Culturing cells at 35 °C reduces cell growth and metabolism, permitting longer maintenance of B7GG cells. It is also important to keep the culture medium neutral because acidic conditions induce conformation changes of rabies G, fusion of rabies G-expressing cells and 75, 76 . Longer culture times make the medium acidic, but keeping cells at 3% CO 2 slows this process. If the G-deleted rabies virus being produced expresses fluorescence, amplification of the G-deleted rabies virus can be monitored in live cells with fluorescence microscopy (Fig. 5) . Because new virions produced by B7GG cells will infect adjacent cells, the formation of fluorescent clusters of infected cells is a good indication of the progress of virus amplification. During the production of G-deleted rabies virus that does not express fluorescence, viral production must be monitored by the collection of supernatant and subsequent staining of fixed cells with an antibody against either one of the viral genes or a transgene expressed from the viral genome. When you follow the detailed protocol below, it is expected that 90-100% of B7GG cells will be infected and will express viral genes 5-6 d after inoculation (Fig. 3a) .
Stage IV: pseudotyping of rabies virus with EnvA or EnvB
To pseudotype G-deleted rabies viruses with EnvA or EnvB, it is necessary to use unpseudotyped rabies virus to infect cells that will produce the pseudotyped virus (Fig. 3b) . This is required because EnvA-pseudotyped rabies viruses must be grown in baby hamster kidney (BHK)-EnvA cells, but EnvA-pseudotyped rabies viruses cannot infect the BHK-EnvA cells because they do not express a receptor for EnvA (e.g., TVA). The lack of receptors for EnvA in the producer cells affects the way that the virus grows during production and also affects procedures for generating high-quality and pure virus preparations. First, unlike during the amplification of unpseudotyped G-deleted rabies virus using B7GG cells, cluster formation is not observed during the production of EnvApseudotyped rabies viruses because the EnvA-pseudotyped virus that is produced is not able to infect adjacent cells. More importantly, because the production of pseudotyped viruses begins with the addition of unpseudotyped viruses, the potential is created for the final preparation to be contaminated with the unpseudotyped rabies viruses 23 . It is necessary to take steps to minimize this possibility. To avoid contamination by unpseudotyped G-deleted rabies viruses after the initial infection of the BHK-EnvA cells, we remove the unpseudotyped G-deleted rabies virus-containing medium, wash the infected BHK-EnvA cells with PBS, react the cells with trypsin, spin down the cells, remove the medium, resuspend the cells with fresh medium, re-plate the cells onto new dishes and change the medium. These steps are crucial for the generation of highquality pseudotyped viruses.
Stage V: concentration of virus
To concentrate the virus supernatant, we perform two rounds of ultracentrifugation to increase the virus titer and remove the culture medium components. After the collection of the supernatant, we strongly recommend that centrifugation be performed as soon as possible because the virus titer decreases over time, even at 4 °C. Freezing and storing the supernatant at − 80 °C can maintain high virus titer, but the freeze-thaw cycle reduces the titer.
Stage VI: titration of virus
To determine the infectious titer of unpseudotyped rabies virus, human embryonic kidney (HEK) 293T cells are used. In contrast, to titer pseudotyped rabies viruses, both HEK 293T cells and HEK 293T-TVA800 cells or HEK 293T-TVB cells are necessary. The HEK 293T-TVA800 cells or HEK 293T-TVB cells are used for the titration of EnvA-pseudotyped or EnvB-pseudotyped rabies viruses, respectively, whereas the HEK 293T cells are used to check for contamination by unpseudotyped rabies viruses. If infection is observed in HEK 293T cells, the preparation is contaminated and should be discarded. Experimental use will probably result in nonspecific infection of neurons that do not express TVA or TVB. Measuring infectious titers on cells is preferable to using genomic titers because quantitative PCR (qPCR) is not as accurate. This is because qPCR cannot distinguish between infectious virus particles and noninfectious particles. In addition, genomic titers cannot distinguish EnvApseudotyped viruses from unpseudotyped viruses that might be present in contaminated preparations. Comparison with other protocols Our protocol 13 differs from previously published protocols for producing G-deleted rabies virus (as described in refs. 7,33,61).
As mentioned above, we use different plasmids (pSAD∆G-F3), different cell lines (B7GG) and different conditions (35 °C and 3% CO 2 ). Our system can express two transgenes from the viral genome, recover G-deleted rabies viruses at higher efficiency and produce pseudotyped rabies virus at higher purity 13, 23, 61 . In particular, the B7GG cells we generated enable substantially higher success of G-deleted rabies virus recovery than the transient transfection of G that was used in the protocol by Wickersham et al. 61 .
In the previous system, when a single particle of G-deleted rabies virus is recovered by transient transfection with G, the virus cannot amplify if the particle goes on to infect nontransfected cells. Another important difference is that the Wickersham et al. 61 protocol often produces EnvA-pseudotyped rabies virus that is contaminated with unpseudotyped rabies virus 23 . This has been reported by Watabe-Uchida et al. 23 and is confirmed in our lab. The use of contaminated virus for circuit tracing can lead to misleading results and conclusions or data that must be discarded. To obtain pure preparations of pseudotyped viruses, it is important to follow the steps mentioned above to remove unpseudotyped G-deleted rabies virus. Another limitation of the previously published method by Wickersham et al. 61 is that it uses plasmids and reagents that are not as readily available as those described here. In contrast, our plasmids, virus supernatants and cell lines are freely accessible. to recover G-deleted rabies viruses from DNA to produce the same rabies virus variants produced and characterized in our previous publication, the relevant plasmids are described in Osakada et al. 13 and can also be obtained from Addgene. It should be noted that it would typically be more efficient to obtain viral supernatant from the authors and to use this virus to propagate, pseudotype and/or concentrate the virus, as described above. However, from time to time, it might be desirable to recover these viral variants de novo, such as if gradual mutations in the viral genome during repeated passaging result in undesirable traits or if import or export restrictions prevent the transfer of rabies virus.  crItIcal Endotoxin-free preparation of plasmids is not essential for virus production. However, endotoxins in DNA preparation potentially reduce transfection efficiency and viral titer. In addition, endotoxins will induce inflammation, glial activation and malfunction of neural responses after virus injection in the brain. Thus, we recommend endotoxin-free preparation of plasmids. 
MaterIals

REAGENTS
Other reagents
HiSpeed plasmid maxi prep kit (Qiagen, cat. no. 12663) QIAquick gel extraction kit (Qiagen, cat. no. 28704) REAGENT SETUP Culture medium Add 50 ml of FBS to 500 ml of DMEM and store it at 4 °C for up to 2 weeks.  crItIcal The efficiency of rabies virus production depends on the quality of FBS. We recommend testing several lots in advance and then investing in large quantities from the best lot to ensure consistent future production.  crItIcal We use culture medium without antibiotics because any contamination will be immediately apparent. This saves time by avoiding continuation of the protocol with a preparation in which contamination will only become apparent later. Because rabies virus amplification is based on passaging the culture supernatant, once the supernatant becomes contaminated it continues to carry the contamination to subsequent dishes. It is better to identify the contamination as soon as possible and discard the preparation immediately if it is contaminated. Cell freezing solution Mix 8 ml of DMEM, 1 ml of FBS and 1 ml of DMSO.
Freshly prepare the solution and cool it at 4 °C until use. For larger volumes, increase the component amounts proportionally. Sucrose/HBSS, 20% (wt/vol) Mix 20 g of sucrose with 10 ml of 10× HBSS, adjust the total volume to 100 ml with distilled water and sterilize the solution by passing it through a 0.22-µm filter. For larger volumes, increase the component amounts proportionally. The solution can be stored at 4 °C for several months.
• • proceDure  crItIcal In the event that there already exists an available starter stock for a particular rabies virus 13 , stages I and II are not necessary. Stage IV is only required in the event that pseudotyped virus is required.
stage I: design, construction and preparation of rabies virus vector • tIMInG 1-3 weeks 1|
Select the transgenes of interest. The description here is based on the use of pSAD∆G-F3 as a starting plasmid that contains the G-deleted SAD-B19 rabies viral genome and convenient restriction sites to facilitate the incorporation of one or two genes of interest. Choose unique restriction enzyme sites in the pSAD∆G-F3 plasmid sequence to enable cloning of your transgenes. Prepare the rabies virus vector backbone, such as pSAD∆G-F3, and digest the plasmid with chosen restriction enzyme(s) to obtain a backbone fragment.  crItIcal step If you use two different restriction enzyme sites that produce noncompatible ends, it is possible to clone a fragment unidirectionally into the rabies virus genomic vector. However, if you use one restriction enzyme site, ligated products have two directions of insertion, and it is therefore essential to verify that the direction of the inserted gene is the desired one.
2|
Perform electrophoresis of your digested plasmid on a 0.7% (wt/vol) agarose gel in 1× TAE buffer.
3|
Cut the gel containing the desired backbone fragment under longer-wavelength UV illumination (360 nm) as quickly as possible. Gel-purify the fragment with the QIAquick gel extraction kit according to the manufacturer's instructions, and then elute it in water.  crItIcal step Minimize UV exposure in order to reduce DNA damage. Exposure to short-wavelength UV for long periods induces mutations in DNA.
4|
Obtain an insert DNA fragment. If you have more than one unique restriction site in your transgene, follow option A. If you find only one unique restriction enzyme site in your transgene, follow option B; the cloning will require extra steps. If there are no unique restriction enzyme sites in your transgene, follow option C; you will need extra steps after digesting your insert. Option D is another option for cloning transgenes into the rabies virus genome using the In-Fusion system (Clontech). The In-Fusion system allows directional cloning in a single reaction without restriction digestion of inserts, phosphatase treatment of vectors or ligation. Digestion of PCR-generated inserts with restriction enzymes is not required for In-Fusion cloning because In-Fusion enzyme fuses DNA fragments (PCR-generated sequences and linearized vectors) by recognizing a 15-bp overlap at their ends.  crItIcal step Virus packaging capacity is limited. PCR is ideal to minimize the insert size.  crItIcal step The Kozak consensus sequence has a major role in the initiation of the translation process.  crItIcal step In general, to cleave efficiently, 6 bp should be added at the end of the recognition site. (ii) Amplify a DNA fragment containing restriction enzyme sites by PCR. Set 25 cycles of PCR using a high-fidelity polymerase such as Phusion polymerase.  crItIcal step A proofreading high-fidelity polymerase that has a 3′-5′ exonuclease activity is essential to avoid PCR errors.  crItIcal step To reduce mutation, keep the number of amplification cycles to < 25.  crItIcal step It is better to add DMSO or other similar agents to weaken hydrogen bonding and prevent the formation of hairpin structures, although this depends on the sequence of the ORF and the designed primers. (iii) Perform electrophoresis on 0.7-1.0% (wt/vol) agarose gel in 1× TAE buffer.
 crItIcal step The agarose concentration depends on the product size. , and then gel-purify the digested vector as described at Steps 1-3. Treat it with Klenow or T4 DNA polymerase to produce blunt ends, and then purify it by spin-column purification or phenol extraction.  crItIcal step Any combination of restriction enzyme sites will work for cloning, but if your transgene is larger it would be better to choose enzyme sites that make the rabies viral genome smaller.  crItIcal step You need to check the direction of insert DNA because this strategy produces two types of clones that have two different insert directions. (ii) To obtain an insert, design a set of primers, amplify the transgene by PCR using a high-fidelity polymerase such as Phusion polymerase, and then purify the PCR product.  crItIcal step A high-fidelity polymerase that possesses a 3′-5′ exonuclease proofreading activity generates blunt-ended PCR products. (ii) Perform 25 cycles of PCR using Phusion polymerase with primers designed in Step 4D(i).  crItIcal step Set the PCR using a high-fidelity polymerase such as Phusion polymerase. A proofreading high-fidelity polymerase is essential in order to avoid PCR errors.  crItIcal step To reduce mutation, keep the number of amplification cycles to <25.  crItIcal step It is better to add DMSO or other similar agents to weaken hydrogen bonding and prevent the formation of hairpin structures, although this depends on the sequence of the ORF and the designed primers. (iii) Perform electrophoresis on 0.7-1.0% (wt/vol) agarose gel in 1× TAE buffer.
 crItIcal step The agarose concentration depends on the product size. (iv) Cut the gel containing the desired size fragment under longer-wavelength UV illumination (360 nm) as quickly as possible, gel-purify it with the QIAquick gel extraction kit according to the manufacturer's instructions and then elute it in water.  crItIcal step Exposure to short-wavelength UV for long periods induces mutations in DNA. Minimize UV exposure to reduce DNA damage. 
6|
Digest the purified PCR product with the restriction enzyme(s) that you used to design primers.
7|
Perform electrophoresis on 0.7-1.0% (wt/vol; the concentration depends on the product size) agarose gel in 1× TAE buffer.  crItIcal step Confirm that there is a single band of the desired size.
8|
Excise the band of the desired size, gel-purify it with the QIAquick gel extraction kit according to the manufacturer's instructions and then elute it in water.
9|
Ligate the rabies viral backbone vector with the insert DNA fragment according to the manufacturer's instructions. A vector/insert ratio of 1:3-1:10 should be ideal, but we recommend mixing vectors and inserts at several different ratios.
10|
Transform chemically competent SC33 cells with the ligation reaction mix or the In-Fusion reaction mix. Apply 1-2 µl of the reaction mix to SC33 cells that are thawed on ice.
11|
Incubate the SC33 cells on ice for 10 min.
12|
Incubate the SC33 cells at 42 °C for 45 s. Incubate the cells on ice for 2 min.
13| Add 250 µl of SOC medium to the cells and shake them at 37 °C for 45 min at 225 r.p.m. in a shaking incubator.
14|
To select and collect transformants, spread 20 and 200 µl of the cells onto carbenicillin (100 µg ml − 1 )-or ampicillin (100 µg ml − 1 )-containing LB agar plates. Invert the plates and incubate them at 37 °C overnight.
15|
Check colony formation on the plate. Pick up the resulting colonies to screen for the correct plasmid DNA. Start mini cultures in LB medium containing carbenicillin (100 µg ml − 1 ) or ampicillin (100 µg ml − 1 ).  crItIcal step We typically pick eight colonies in order to assure that at least one will be correct.  crItIcal step Colony PCR is also effective for screening positive colonies. In brief, pick up a single colony with a micropipette tip, make a replicate of the clone in a new LB plate or LB medium and then pipette it up and down in the PCR mixture in the PCR tube. Perform PCR followed by agarose gel electrophoresis. If you get positive clones, start mini-cultures for positive clones.
16| Extract plasmid DNA from the mini-cultures using a plasmid mini prep kit according to the manufacturer's instructions.
17|
Check the plasmids by diagnostic digestions with appropriate restriction enzymes to confirm the insert. Run the digests on agarose gel using electrophoresis and confirm the digestion pattern to obtain a correct clone.  crItIcal step If you use a single restriction enzyme site for cloning, confirm that your cloned transgene is inserted in the proper orientation.
? trouBlesHootInG 18| Start maxi-culture of the expected clone in 250 ml of LB medium containing carbenicillin (100 µg ml − 1 ) or ampicillin (100 µg ml − 1 ) by transforming SC33-competent cells and picking up a single colony as described in Steps 10-14.
19|
Extract the plasmid using a plasmid maxi prep kit.
20|
Sequence the plasmid to check that the clone has the correct sequence.  crItIcal step If the clone that you sequenced has mutations, try another clone in Step 17. 24| Add the contents of tube A to tube B, and then vortex the tube five times for 3 s.
25|
Let the tube stand at room temperature for 15 min.
Box 1 | Maintenance of B7GG cells • tIMInG 1 h
The quality of G-deleted rabies virus depends on the condition of B7GG cells. It is also important to generate and store a large number of frozen stocks of B7GG cells at a low passage number. Here we describe how to prepare B7GG cells. 1. Prepare a subconfluent dish of B7GG cells.  crItIcal step Do not let them grow to 100% confluency. When the dish becomes subconfluent (80-90% of the dish), it is time to split the cells. 2. Aspirate the medium from the dish, wash the dish with 10 ml of PBS, add 4 ml of prewarmed 0.25% (wt/vol) trypsin-EDTA and incubate the dish at 37 °C for 5-6 min.  crItIcal step Confirm that the cells are detached from the dish by tapping the dish. If cells are still attached to the dish, incubate it for an additional 1-2 min. 3. Gently dissociate the cells with a P1000 micropipette.  crItIcal step Pipetting at this step is important. B7GG cells must be single, not in clumps (3-5 cells). Clumps of B7GG cells do not grow well in a dish. 4. Add 4 ml of medium and collect the cell suspension in a 50-ml conical tube. 5. To collect the remaining cells on the dish, apply an additional 5 ml of medium and transfer the cell suspension into the 50-ml conical tube.  crItIcal step Collect all of the cells. If you do not collect all of them, the split ratio will be decreased. 6. Centrifuge the 50-ml tube for 3 min at 200g at room temperature. 7. Aspirate the supernatant carefully, apply 10 ml of prewarmed medium and dissociate the suspension into single cells by pipetting with a P1000 micropipette. 8. To split the cells at a 1:5 ratio, mix 20 ml of prewarmed medium and 2 ml of the cell suspension in a 50-ml tube, and then plate 22 ml of the cell suspension on a 150-mm dish.  crItIcal step Keep the split ratio at 1:5-1:10. Culturing B7GG cells at a lower cell density causes changes in cell morphology and rate of proliferation, which seem to be detrimental to efficient viral production. 9. Maintain the dishes in a humidified atmosphere of 5% CO 2 at 37 °C. One day after plating B7GG cells at a 1:5 ratio, the cells will typically be ready for rabies virus amplification.
26| Add 2.5 ml of the A + B mixture evenly in a dropwise manner onto the 10-cm dish of B7GG cells. The total volume of the medium will be around 8 ml. Incubate the dish at 5% CO 2 and 37 °C.
27|
Six hours later, remove the medium, wash the dish with 10 ml of 10% (vol/vol) FBS/DMEM and add 10 ml of 10% (vol/vol) FBS/DMEM. Incubate the dish at 5% CO 2 and 37 °C overnight.
28|
On day 1, transfer the dish to an incubator; incubate it at 3% CO 2 and 35 °C overnight.
29|
On day 2, wash the dish with PBS, add 4 ml of 0.25% (wt/vol) trypsin-EDTA and then incubate the dish for 5-6 min at 37 °C.
30| Detach the cells from the 10-cm dish and dissociate the cells into single cells by pipetting them with a P1000 micropipette. Add 5 ml of 10% (vol/vol) FBS/DMEM and collect the cell suspension in a conical tube. Add an additional 10 ml of 10% (vol/vol) FBS/DMEM to the dish to collect any remaining cells, and transfer this rinse to the tube containing the cells.
31|
Centrifuge the tube at 200g for 3 min at room temperature and remove the supernatant. Gently tap the bottom of the tube to loosen the cell pellet, add 10 ml of 10% (vol/vol) FBS/DMEM and gently resuspend the pellet by pipetting it up and down with a P1000 micropipette.
32|
Plate the cell suspension in a new 150-mm dish. Incubate the dish at 3% CO 2 and 35 °C overnight.
33|
On day 3, remove the supernatant and add 24 ml of fresh 10% (vol/vol) FBS/DMEM. Incubate the dish at 3% CO 2 and 35 °C for 2 d.
34|
On day 5, add 5 ml of fresh 10% (vol/vol) FBS/DMEM to the 150-mm dish, and incubate the dish for 2 d.
35|
On day 7, collect the supernatant and filter the collected supernatant by using a 0.45-µm filter. Add 24 ml of fresh 10% (vol/vol) FBS/DMEM to the 150-mm dish, and then incubate the dish at 3% CO 2 and 35 °C for 2 d.  crItIcal step The timing of the collection of supernatant depends on the speed at which the virus spreads, as well as the condition of the cells (Fig. 4) . The cells and their GFP (or RFP) signals should be checked under a microscope every day.
36|
On day 9, add 5 ml of fresh 10% (vol/vol) FBS/DMEM to the 150-mm dish; incubate it for 2 d. 
48|
Aspirate the medium from ten 15-cm dishes of BHK-EnvA cells, and then apply the supernatant of unpseudotyped G-deleted rabies virus to obtain an MOI of 0.5-0.6. For example, apply 10 ml of filtered supernatant of unpseudotyped G-deleted rabies virus to each dish, and then apply 10 ml of fresh 10% (vol/vol) FBS/DMEM.
49|
Maintain the dishes in a humidified atmosphere of 3% CO 2 at 35 °C for 6 h.
50|
Five to six hours later, aspirate the medium from infected BHK-EnvA cell dishes and rinse the dishes with PBS (without Ca and Mg) twice to remove unpseudotyped viruses. Tilt and swirl the plates to wash out any unpseudotyped viruses from the walls of the plates.  crItIcal step Minimizing the remnants of starter supernatant of unpseudotyped rabies viruses is crucial to making high-purity pseudotyped rabies virus.
51|
Remove PBS, apply prewarmed 5 ml of 0.25% (wt/vol) trypsin-EDTA and incubate the dish at 37 °C for 3 min to destroy residual rabies G.  crItIcal step This step is essential for the production of well-pseudotyped virus.
52| Detach the cells completely by pipetting, apply 5 ml of 10% (vol/vol) FBS/DMEM and collect the cells into a 50-ml conical tube. To collect the remaining cells on the dish, apply an additional 5 ml of medium to the dish and transfer the cell suspension into the 50-ml conical tubes.
53|
Centrifuge the tube at 200g for 3 min at room temperature and remove the supernatant to remove remnants of native rabies virus G-enveloped, unpseudotyped G-deleted rabies viruses.
54|
Resuspend the cells with medium and plate the cell suspension onto ten new 15-cm dishes at 23 ml per dish. Maintain the dishes in a humidified atmosphere of 3% CO 2 at 35 °C overnight.
55|
On day 1, remove the medium in order to remove both unpseudotyped viruses and dead cells. Add 23 ml of fresh prewarmed medium. Incubate the cells for 2 d.  crItIcal step The first supernatant may be contaminated with the initially applied unpseudotyped viruses.
56|
On day 3, collect the supernatant from the ten virus-infected 15-cm dishes, and filter it through a 0.45-µm filter. If you need to concentrate the supernatant, please see stage V below and follow Steps 57-67.
stage V: concentration of the virus by ultracentrifugation • tIMInG 1 d 57| Apply 35 ml of the supernatant to each of six centrifuge tubes in the hood. Make sure to prepare a proper counterbalance.  crItIcal step For the first centrifugation, use the Beckman SW28 rotor. This rotor holds 35 ml × 6 tubes = a total capacity of 210 ml.
58|
Spin down the viral supernatant at 70,000g for 2 h at 4 °C. Use the Beckman SW28 rotor at 19,400 r.p.m.
59|
Stop the centrifuge, move the centrifuged tubes back to the hood and gently remove the supernatant by pouring it off and allowing the remaining liquid to drain by resting the inverted tubes on paper towels. Remove all liquid from the pellet using an aspirator. The pellet should be barely visible as a small translucent spot.
60|
Resuspend each pellet in 300 µl of HBSS, wrap the top of the tubes in Parafilm and agitate the tubes on a low-speed vortex five times for 5 s.
61|
For the second centrifugation, place 2.5 ml of HBSS/20% (wt/vol) sucrose in a round-bottom tube that is suitable for a Beckman SW55 rotor.
62|
Gently pipette the viral suspension up and down and transfer 1.8 ml of the viral suspension from the six tubes (300 µl × 6 tubes) on top of the sucrose cushion.  crItIcal step Avoid creating air bubbles.
63|
Rinse the tubes with 200 µl of HBSS to recover any remaining rabies virus and transfer the suspension to the sucrose cushion again. Make sure to prepare a proper counterbalance.
64|
Spin the suspension at 50,000g for 2 h at 4 °C. Use the SW55 rotor at 21,000 r.p.m.
65|
Two hours later, stop the second centrifugation, move the centrifuged tubes back to the hood, gently remove the supernatant as described in Step 59 and then resuspend the viral pellets in 100 µl of cold HBSS.
66|
Wrap the tubes with Parafilm, agitate the tube on a low-speed vortex for 3 s, 7-10 times, and keep the tubes at 4 °C for 1 h.
67|
Gently pipette the viral suspensions up and down; make aliquots of the virus (3-5 µl each) and freeze them at −80 °C for future use.  crItIcal step Avoid producing bubbles during pipetting.  pause poInt Concentrated virus can be frozen at − 80 °C for at least 3-4 years. However, avoid freeze-thaw cycles of frozen stocks, as this reduces the viral titer. antIcIpateD results Our protocols produce consistent outcomes when appropriate attention is paid to the conditions of the producer cells (B7GG cells, BHK-EnvA cells and BHK-EnvB cells), to the passage number of cells and viruses and to the storage of generated viruses. We routinely produce concentrated stocks of unpseudotyped rabies viruses and EnvA-or EnvB-pseudotyped rabies viruses at 10 9 and 10 8 infectious units per ml, respectively 13 . Unpseudotyped rabies viruses at greater than 5 × 10 8 infectious units per ml and pseudotyped rabies viruses at higher than 3 × 10 7 infectious units per ml work well for in vivo circuit tracing experiments [8] [9] [10] [11] [12] [13] 15 . Dilutions of viruses (at 1/10-1/100) allow sparse labeling of neurons, depending on the design and purpose of the experiments. Injection of unpseudotyped G-deleted rabies viruses will label long-range projection neurons in a retrograde direction, whereas VSV-G-pseudotyped rabies viruses will locally infect neurons around an injection site 6, 8, 13, 15 . When TVA or TVB is introduced in a particular cell type or a single cell (e.g., by using a cell type-specific promoter, a Cre-, FLP-or tTA-dependent system, bridge proteins, electroporation or targeted patching in vitro or in vivo), EnvA-or EnvB-pseudotyped rabies viruses can be used to selectively infect the TVA-or TVB-expressing cells, respectively. With gene transfer of G, transcomplementation of G-deleted rabies virus makes it possible to spread G-deleted rabies virus to presynaptic neurons that are directly connected to G-expressing starter cells. It should be noted that only monosynaptically connected neurons are infected and labeled with G-deleted rabies virus after transcomplementation. The high-resolution circuit tracing can be combined with functional assays monitoring or manipulating neural activity and gene expression. These studies will make it possible to link the structure to the function of neural circuits. The titer of the starter stock is low
Use one 100-mm dish for the first amplification, and then scale up to 15-cm dishes
